FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dan Cacsire Castillo-Tong

Research Profile

Disorders

Procedures

Anatomy

Geographic Areas

Austria

Chemicals & Drugs

Physiology

Gene Expression Regulation, Neoplastic

Concepts & Ideas

Neoplasm Staging

Co-author Network

Publications

TOP 3
Dietmar Pils; Jalid Sehouli; Dan Cacsire Castillo-Tong; Petr Vanhara; Michael Wittinger; Robert Zeillinger; Michaela Petz; Angela Alfanz; Mariam Anees; Veronika Auner; Elena Ioana Braicu; Andreas Gleiss; Alfred Gugerell; Peter Horak; michael krainer
Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
Dietmar Pils; Eva Schuster; Jalid Sehouli; Paul Speiser; Dan Cacsire Castillo-Tong; Toon Van Gorp; Ignace Vergote; Andrea Wolf; Stefanie Aust; Ioana Braicu; Nicole Concin; Gudrun Hager; Georg Heinze; Maria Kohl; Sven Mahner; Eva Obermayr; Robert Zeillinger
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium.
Stefanie Aust; Christoph Grimm; Peter Horak; Reinhard Horvat; Dietmar Pils; Sophie Pils; Alexander Reinthaller; Bernd Schmid; Paul Speiser; Dan Cacsire Castillo-Tong; Stephan Polterauer
The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dan Cacsire Castillo-Tong (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Dietmar Pils; Jalid Sehouli; Dan Cacsire Castillo-Tong; Petr Vanhara; Michael Wittinger; Robert Zeillinger; Michaela Petz; Angela Alfanz; Mariam Anees; Veronika Auner; Elena Ioana Braicu; Andreas Gleiss; Alfred Gugerell; Peter Horak; michael krainer
Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
Cancer 2013;119(5):946-54.
2013: Dietmar Pils; Eva Schuster; Jalid Sehouli; Paul Speiser; Dan Cacsire Castillo-Tong; Toon Van Gorp; Ignace Vergote; Andrea Wolf; Stefanie Aust; Ioana Braicu; Nicole Concin; Gudrun Hager; Georg Heinze; Maria Kohl; Sven Mahner; Eva Obermayr; Robert Zeillinger
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium.
BMC cancer 2013;13():178.
2013: Stefanie Aust; Christoph Grimm; Peter Horak; Reinhard Horvat; Dietmar Pils; Sophie Pils; Alexander Reinthaller; Bernd Schmid; Paul Speiser; Dan Cacsire Castillo-Tong; Stephan Polterauer
The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
BMC cancer 2013;13():115.
2012: Dietmar Pils; Eva Schuster; Jalid Sehouli; Paul Speiser; Dan Cacsire Castillo-Tong; Ignace Vergote; Andrea Wolf; Stefanie Aust; Ioana Braicu; Isabelle Cadron; Gudrun Hager; Georg Heinze; Gerda Hofstetter; Maria Kohl; Sven Mahner; Robert Zeillinger
Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
Cancer science 2012;103(7):1334-41.
2012: Stefanie Aust; Anna Bachmayr-Heyda; Radoslav Chekerov; Silvia Darb-Esfahani; Carsten Denkert; Reinhard Horvat; Sven Mahner; Petra Pateisky; Jalid Sehouli; Paul Speiser; Dan Cacsire Castillo-Tong; Toon Van Gorp; Ignace Vergote; Robert Zeillinger; Dietmar Pils
Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium.
Molecular cancer 2012;11():69.
2011: Martin Svoboda; Barbara Taferner; Theresia Thalhammer; Dan Cacsire Castillo-Tong; Katrin Wlcek; Robert Zeillinger; Steffen Hering; Bruno Stieger; Walter Jäger
Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2011;65(6):417-26.
2011: Christoph Grimm; Rafal Watrowski; Konstantin Baumühlner; Camilla Natter; Dan Cacsire Castillo-Tong; Andrea Wolf; Robert Zeillinger; Sepp Leodolter; Alexander Reinthaller; Lukas Hefler
Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia.
Gynecologic oncology 2011;121(3):537-41.
2010: Dan Cacsire Castillo-Tong; Georg Heinze; Dietmar Pils; Andrea Wolf; Christian F Singer; Nicole Concin; Gerda Hofstetter; Ingrid Schiebel; Margaretha Rudas; Robert Zeillinger
Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients.
BMC cancer 2010;10():682.
2010: Eva Obermayr; Fatima Sanchez Cabo; Muy-Kheng M Tea; Christian F Singer; michael krainer; Michael B Fischer; Jalid Sehouli; Alexander Reinthaller; Reinhard Horvat; Georg Heinze; Dan Cacsire Castillo-Tong; Robert Zeillinger
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
BMC cancer 2010;10():666.
2007: Alexander Mustea; Georg Heinze; Jalid Sehouli; Dominique Koensgen; Andrea Wolf; Lilian Gutu; Dumitru Sofroni; Cristina Pirvulescu; Elena Ioana Braicu; Eva Schuster; Robert Zeillinger; Dan Cacsire Castillo-Tong
The -463G/A polymorphism in myeloperoxidase gene and cervical cancer.
Anticancer research 2007;27(3B):1531-5.
2007: Alexander Mustea; Jalid Sehouli; Gerhild Fabjani; Dominique Koensgen; V Möbus; Elena Ioana Braicu; Cristina Pirvulescu; Anke Thomas; Dan Cacsire Castillo-Tong; Robert Zeillinger
Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot study.
Anticancer research 2007;27(3B):1527-30.
2006: Dominik Denschlag; Eva-Katrin Bentz; Lukas Hefler; Detlef Pietrowski; Robert Zeillinger; Clemens Tempfer; Dan Cacsire Castillo-Tong
Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome P450 17 gene polymorphisms in Caucasian women with uterine leiomyomas.
Fertility and sterility 2006;85(2):462-7.
2005: Nicole Concin; Gerda Hofstetter; Astrid Berger; Adriana Gehmacher; Daniel Reimer; Rafal Watrowski; Dan Cacsire Castillo-Tong; Eva Schuster; Lukas Hefler; Kurt Heim; Elisabeth Mueller-Holzner; Christian Marth; Ute M Moll; Alain G Zeimet; Robert Zeillinger
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8372-83.
2005: Gerhild Fabjani; Dan Cacsire Castillo-Tong; Andrea Wolf; Sebastian Roka; Sepp Leodolter; Paul Hoecker; Michael B Fischer; Raimund Jakesz; Robert Zeillinger
HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.
Oncology reports 2005;14(3):737-41.
2004: Dan Cacsire Castillo-Tong; Eva Schuster; Klaus Czerwenka; Sepp Leodolter; Robert Zeillinger
Loss of heterozygosity on chromosome 13q: suggestion of a candidate tumor suppressor gene in sporadic breast cancer.
Breast cancer research and treatment 2004;83(2):143-8.
2003: Dan Cacsire Castillo-Tong; Tanja Volm; Elke Eberhardt; michael krainer; Sepp Leodolter; Rolf Kreienberg; Robert Zeillinger
Rad52 gene mutations in breast/ovarian cancer families and sporadic ovarian carcinoma patients.
Oncology reports 2003;10(5):1551-3.
2003: Nicole Concin; Christa Zeillinger; Dan Cacsire Castillo-Tong; Margit Stimpfl; Margit König; Dieter Printz; Felix Stonek; Christian Schneeberger; Lukas Hefler; Christian Kainz; Sepp Leodolter; Oskar A Haas; Robert Zeillinger
Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines.
Breast cancer research and treatment 2003;79(1):37-46.
2002: Bernd Schmid; Lakjaya Buluwela; QiuYan Liu; Barbara Fasching; Dan Cacsire Castillo-Tong; Margit Stimpfl; Obermair Andreas; Sepp Leodolter; Robert Zeillinger
Expression of MUCI splice variants correlates with invasive growth of breast cancer cell lines.
Breast cancer research and treatment 2002;76(3):211-9.
2002: Margit Stimpfl; Dan Cacsire Castillo-Tong; Barbara Fasching; Eva Schuster; Andreas Obermair; Sepp Leodolter; Robert Zeillinger
Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2253-9.
2002: Gerhild Fabjani; Dan Cacsire Castillo-Tong; Klaus Czerwenka; Eva Schuster; Paul Speiser; Sepp Leodolter; Robert Zeillinger
Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women.
Breast cancer research and treatment 2002;72(2):131-7.
2002: Dan Cacsire Castillo-Tong; Eva Schuster; Michael Seifert; Klaus Czerwenka; Sepp Leodolte; Robert Zeillinger
Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines.
Breast cancer research and treatment 2002;71(3):249-55.
2002: Fritz Wieser; Christian Schneeberger; Dan Cacsire Castillo-Tong; Clemens Tempfer; Johannes C Huber; Rene Wenzl
PROGINS receptor gene polymorphism is associated with endometriosis.
Fertility and sterility 2002;77(2):309-12.
2001: Dan Cacsire Castillo-Tong; Gerhild Fabjani; Georg Heinze; Andreas Obermair; Sepp Leodolter; Robert Zeillinger
Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients.
International journal of cancer. Journal international du cancer 2001;95(6):394-7.
2000: Dan Cacsire Castillo-Tong; Elisabeth Kucera; Eva Schuster; Rita K Schmutzler; H Swoboda; Alexander Reinthaller; Sepp Leodolter; Robert Zeillinger
Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors.
International journal of cancer. Journal international du cancer 2000;88(2):319-22.
2000: Elisabeth Kucera; Dan Cacsire Castillo-Tong; Alexander Reinthaller; Sepp Leodolter; Robert Zeillinger; Gerhard Sliutz
p53 polymorphism at codon 72--does it constitute a risk for squamous intraepithelial lesions and invasive cancer of the cervix in Central Europeans?
Wiener klinische Wochenschrift 2000;112(18):817-20.
2000: Nicole Concin; Christa Zeillinger; M Stimpfel; Ingrid Schiebel; Dan Cacsire Castillo-Tong; Uwe Wolff; A Reiner; Sepp Leodolter; Robert Zeillinger
p53-dependent radioresistance in ovarian carcinoma cell lines.
Cancer letters 2000;150(2):191-9.
2000: Dan Cacsire Castillo-Tong; Elisabeth Kucera; Margit Stimpfl; Heinz Kölbl; Sepp Leodolter; Robert Zeillinger
Detection of p53 polymorphism at codon 72 by PCR and allele-specific oligonucleotide hybridization on microtiter plates.
Clinical chemistry 2000;46(1):124-6.
1999: Margit Stimpfl; Bernd Schmid; Ingrid Schiebel; Dan Cacsire Castillo-Tong; Sepp Leodolter; Andreas Obermair; Robert Zeillinger
Expression of mucins and cytokeratins in ovarian cancer cell lines.
Cancer letters 1999;145(1-2):133-41.
1999: Dan Cacsire Castillo-Tong; Klaus Czerwenka; Jan Sedlak; Christian Schneeberger; Ingrid Schiebel; Nicole Concin; Sepp Leodolter; Robert Zeillinger
Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines.
Breast cancer research and treatment 1999;56(1):91-7.
1999: Dan Cacsire Castillo-Tong; Margit Stimpfl; Alexander Reinthaller; N Vavra; S Müllauer-Ertl; Sepp Leodolter; Robert Zeillinger
BRCA1 gene mutations in sporadic ovarian carcinomas: detection by PCR and reverse allele-specific oligonucleotide hybridization.
Clinical chemistry 1999;45(7):976-81.
1999: Dan Cacsire Castillo-Tong; Christian Schneeberger; Klaus Czerwenka; Rita K Schmutzler; Paul Speiser; Elisabeth Kucera; Nicole Concin; Ernst Kubista; Sepp Leodolter; Robert Zeillinger
Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1497-502.
1999: Margit Stimpfl; Bernd Schmid; Andreas Obermair; Dan Cacsire Castillo-Tong; Ingrid Schiebel; G Gitsch; Sepp Leodolter; Robert Zeillinger
Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood.
Oncology research 1999;11(8):367-73.
1997: Dan Cacsire Castillo-Tong; Christian Schneeberger; Sepp Leodolter; Robert Zeillinger
Quantitative determination of gene expression by competitive reverse transcription-polymerase chain reaction in degraded RNA samples.
Analytical biochemistry 1997;251(2):173-7.